Tyrosine metabolic reprogramming coordinated with the tricarboxylic acid cycle to drive glioma immune evasion by regulating PD‐L1 expression

Due to the existence of the blood–brain barrier in glioma, traditional drug therapy has a poor therapeutic outcome. Emerging immunotherapy has been shown to have satisfactory therapeutic effects in solid tumors, and it is clinically instructive to explore the possibility of immunotherapy in glioma....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ji‐Yan, Dai, Xin‐Tong, Gao, Qing‐Le, Chang, Hong‐Kai, Zhang, Shuai, Shan, Chang‐Liang, He, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529206/
https://www.ncbi.nlm.nih.gov/pubmed/37786553
http://dx.doi.org/10.1002/ibra.12107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529206/
https://www.ncbi.nlm.nih.gov/pubmed/37786553
http://dx.doi.org/10.1002/ibra.12107

Ejemplares similares